oral levofloxacin

DRUG2 trials

Sponsors

Pfizer, University of Rochester

Conditions

Chronic RhinosinusitisCommunity-Acquired Pneumonia (CAP)

Phase 3

Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations

CompletedNCT01988779

University of RochesterChronic Rhinosinusitis

Start: 2013-10-31End: 2020-12-31Updated: 2021-03-24

Phase 4

Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia

CompletedNCT00035347

PfizerCommunity-Acquired Pneumonia (CAP)

Start: 2001-01-31End: 2002-06-30Updated: 2017-03-10